Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PAVmed Inc. Director's Dealing 2017

Aug 23, 2017

35221_dirs_2017-08-23_b2851af1-6620-4dd1-91b3-e40a2380ee0a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PAVmed Inc. (PAVM)
CIK: 0001624326
Period of Report: 2017-08-21

Reporting Person: MCGRATH DENNIS M (EVP & CFO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-08-21 Common Stock P 500 $4.0921 Acquired 500 Indirect
2017-08-21 Common Stock P 500 $4.2178 Acquired 1000 Indirect
2017-08-21 Common Stock P 500 $4.2249 Acquired 1500 Indirect
2017-08-21 Common Stock P 1000 $4.2414 Acquired 2500 Indirect
2017-08-21 Common Stock P 500 $4.2417 Acquired 3000 Indirect
2017-08-22 Common Stock P 500 $4.1233 Acquired 3500 Indirect
2017-08-22 Common Stock P 500 $4.1474 Acquired 4000 Indirect
2017-08-22 Common Stock P 500 $4.235 Acquired 4500 Indirect
2017-08-22 Common Stock P 500 $4.2418 Acquired 5000 Indirect
2017-08-22 Common Stock P 500 $4.2419 Acquired 5500 Indirect
2017-08-22 Common Stock P 500 $4.2499 Acquired 6000 Indirect